Since breast carcinomas are frequently negative or only focally positive for p63, a homolog of p53, whereas adnexal carcinomas are usually strongly and diffusely positive for this marker, it can be beneficial in such scenarios [12]. The gene discussed is TP53; the disease is breast carcinoma.